MMR and Varicella Vaccine in Premature Infants

Completed

Conditions studied: Chickenpox, Rubella, Rubeola, Mumps

In brief

This research is designed to address the question, "Does the relative deficit in vaccine immunogenicity in extremely premature infants persist beyond the first 6 months of life?" We propose to measure the immunogenicity of varicella and mumps-measles-rubella vaccines in relatively healthy, 12-to-15 month-old children born at \<29 weeks gestation, when compared to full-term infants, as measured by the relevant viral serologies.

Key facts

Study ID
NCT00156559
Run by
University of Rochester
People needed
32
Starts
2004-01-01
Expected to finish
2005-05-01
Last updated by the study team
2015-09-17

Who can join

Age: 1 and older, up to 1. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.